INCYTE CORPORATION
Patent Owner
Stats
- 72 US PATENTS IN FORCE
- 19 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 72 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 7,869 Total Citation Count
- Feb 17, 1995 Earliest Filing
- 331 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0283,783 HUMAN BETA-ADRENERGIC RECEPTOR KINASE POLYPEPTIDE AND METHODSJun 15, 17Oct 05, 17[C12N, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9918990 Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitorsJun 20, 16Mar 20, 18[A61K, C07D]
9890162 Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitorsJan 13, 17Feb 13, 18[C07D]
9885717 Methods for detecting expression levels of human signal peptide-containing proteins (HSPP)Aug 11, 16Feb 06, 18[A61K, G01N, C07K]
9822124 Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitorsJul 13, 15Nov 21, 17[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0065,447 SURVIVAL BENEFIT IN PATIENTS WITH SOLID TUMORS WITH ELEVATED C-REACTIVE PROTEIN LEVELSAbandonedAug 19, 14Mar 05, 15[A61K, C07D, G01N]
2014/0227,278 ANTIBODIES TO HUMAN SIGNAL PEPTIDE-CONTAINING PROTEINSAbandonedFeb 11, 14Aug 14, 14[C07K]
2014/0155,377 3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORSAbandonedFeb 06, 14Jun 05, 14[C07D]
8617551 Methods of diagnosing pancreatic inflammation by using chemokine PANEC-1 antibodiesExpiredAug 10, 10Dec 31, 13[A61K, C07K]
2013/0190,250 Polynucleotides Encoding Human Signal Peptide-Containing ProteinsAbandonedSep 14, 12Jul 25, 13[C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.